Address
Email address
Phone number
Website
https://www.fertilitas.eeFertilitas Viimsi uueneb!Fertilitase haiglal on 40-voodikohaline palatikorpus, 4 operatsioonisaali koos intensiivravikeskusega. Kolm polikliinikut Viimsis, Sütiste teel ja Tallinna südalinnas.
Name
AS Viimsi Haigla
Registry code
10391415
VAT number
EE100241798
Type
AS - Joint Stock Company
Status
Registered
Foundation date
23.02.1998 (27)
Financial year
01.01-31.12
Capital
67 095.00 €
Activity
68201 - Rental and operating of own or leased real estate
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ivo Saarma
| 12% - 8 179.20 EUR | Board member | - | Shareholder |
| Ifert OÜ 12131782 | 50% - 33 291.90 EUR | - | - | Shareholder |
| Viisemann Holdings OÜ 10865712 | 38% - 25 623.90 EUR | - | - | Shareholder |
| Avo Leemet
| - | - | - | Board member |
| Inkkeri Soovik
| - | - | - | Board member |
| Omanikukonto: Andres Viisemann
| - | - | - | Chairman of the board |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Seirekliinik OÜ 14430158 | - | - | - | Founder |
| Tallinna Kõrvakliinik OÜ 14364504 | - | - | - | Founder |
| Celvia CC AS 11673707 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 88 066.89 € | 17 987.76 € | 4 233.17 € | 5 |
| 2024 Q3 | 79 151.4 € | 18 548.8 € | 5 358.8 € | 5 |
| 2024 Q2 | 96 878.5 € | 18 380.32 € | 5 925.11 € | 5 |
| 2024 Q1 | 92 594.88 € | 15 420.47 € | 5 638.64 € | 5 |
| 2023 Q4 | 77 993.11 € | 7 922.24 € | 5 549.78 € | 5 |
| 2023 Q3 | 71 815.83 € | 7 362.35 € | 5 724.61 € | 5 |
| 2023 Q2 | 80 596.74 € | 5 743.16 € | 5 355.8 € | 5 |
| 2023 Q1 | 92 444.3 € | 6 377.95 € | 5 294.85 € | 5 |
| 2022 Q4 | 59 016.85 € | 10 955.89 € | 3 659.75 € | 5 |
| 2022 Q3 | 41 638.42 € | 6 319.44 € | 3 114.07 € | 2 |
| 2022 Q2 | 57 900.58 € | 7 806.84 € | 2 397.89 € | 2 |
| 2022 Q1 | 68 056.4 € | 9 604.3 € | 1 996.1 € | 2 |
| 2021 Q4 | 43 332.41 € | 1 306.86 € | 722.23 € | 2 |
| 2021 Q3 | 69 819.14 € | 327 749.41 € | 342 740.04 € | 1 |
| 2021 Q2 | 162 721.44 € | 321 201.59 € | 323 800.83 € | 225 |
| 2021 Q1 | 139 058.01 € | 324 218.16 € | 329 136.6 € | 193 |
| 2020 Q4 | 142 328.79 € | 334 748.52 € | 332 792.12 € | 198 |
| 2020 Q3 | 118 182.72 € | 331 100.67 € | 333 588.65 € | 200 |
| 2020 Q2 | 74 745.91 € | 158 332.24 € | 164 013.7 € | 191 |
| 2020 Q1 | 109 014.2 € | 303 347.06 € | 306 900.18 € | 195 |
